Patients
We performed a retrospective review of patients undergoing aortic cusp
extension valvuloplasty at a large, urban academic medical center
between April 2009 to July 2016. Patients receiving CorMatrix, either
patch or membrane, were compared to those receiving autologous
pericardium irrespective of glutaraldehyde time.